LOINC Panel Details

Panel: 95830-6 - HPC product panel BPU FC

• 95830-6 - HPC product panel BPU FC (Seq: 35, Type: N/A) None
  • 95839-7 - Monos Recovered/Monos Total NFr Patient (Seq: 1, Type: N/A) %
  • 95838-9 - TNC Recovered/TNC NFr Patient (Seq: 2, Type: N/A) %
  • 80698-4 - Viable CD34 cells/CD34 NFr HPC BPU (Seq: 3, Type: N/A) %
  • 95829-8 - Viable CD45 cells/Cells.CD45 NFr BPU (Seq: 4, Type: N/A) %
  • 95832-2 - CD3 dose in HPC transplant Patient (Seq: 5, Type: N/A) 10*6/kg
  • 78002-3 - CD34 dose in HPC per recipient body mass (Seq: 6, Type: N/A) 10*6/kg
  • 14577-1 - ABO + Rh Bld Donr (Seq: 7, Type: N/A) None
  • 95833-0 - Nuc cell BPU (Seq: 8, Type: N/A) 10*8
  • 95834-8 - Mononuc Cells BPU (Seq: 9, Type: N/A) 10*8
  • 95835-5 - CD34 Cells BPU (Seq: 10, Type: N/A) 10*6
  • 95836-3 - CD3 Cells BPU (Seq: 11, Type: N/A) 10*6
  • 95831-4 - Lymphocyte dose in HPC trsplt Patient (Seq: 12, Type: N/A) 10*8/kg
  • 95837-1 - Mono Cell dose in HPC transplant Patient (Seq: 13, Type: N/A) 10*8/kg
  • 78003-1 - Nuc cell dose HPC per recip body mass (Seq: 14, Type: N/A) 10*7/kg
  • 1322-7 - Transf Vol BPU (Seq: 15, Type: N/A) mL
  • 14578-9 - ABO Group Bld BPU (Seq: 16, Type: N/A) None
  • 14907-0 - Rh Bld BPU (Seq: 17, Type: N/A) None
  • 85893-6 - Adverse event note (Seq: 18, Type: N/A) None
  • 931-6 - Bld Prod Source BPU (Seq: 19, Type: N/A) None
  • 936-5 - Bld Unit Id BPU (Seq: 20, Type: N/A) None
  • 18771-6 - Provider signing name (Seq: 21, Type: N/A) None
  • 43414-2 - Num BPU Avail (Seq: 22, Type: N/A) {#};{# units}
  • 82772-5 - Lab result date rep (Seq: 23, Type: N/A) {mm/dd/yyyy}
  • 18771-6 - Provider signing name (Seq: 24, Type: N/A) None
  • 933-2 - Bld Prod Typ BPU (Seq: 25, Type: N/A) None
  • 31208-2 - Specimen source (Seq: 26, Type: N/A) None